Search

Author/Creator Talacchi, A

1. PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period. (9th September 2021)

Authors:
Coomans, M; Dirven, L; Aaronson, N; Baumert, B; van den Bent, M; Bottomley, A; Brandes, A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Stupp, R; Talacchi, A; Wick, W; Reijneveld, J; Taphoorn, M
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 2(2021)
Page Start:
ii2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PL02.4.A International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32. (5th September 2022)

Authors:
Oort, Q; Koekkoek, J; Aaronson, N K; Boele, F W; Brannan, C; Capela, A; Hjermstad, M; Klein, M; Lips, I; Narita, Y; Pace, A; Petranovic, D; Pichler, J; Reijneveld, J C; Sato, H; Seidel, C; Shamieh, O; Sikkes, S A M; Talacchi, A; Uitdehaag, B M J
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 2
Page Start:
ii3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OS05.4.A Do neurocognitive deficits explain the differences between brain tumour patients and their proxies assessing the patient's I-ADL?. (9th September 2021)

Authors:
Oort, Q; Dirven, L; Sikkes, S; Aaronson, N; Boele, F; Brannan, C; Egeter, J; Grant, R; Klein, M; Lips, I; Narita, Y; Sato, H; Sztankay, M; Stockhammer, G; Talacchi, A; Uitdehaag, B; Reijneveld, J; Taphoorn, M
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 2 (2021)
Page Start:
ii7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM). (6th September 2019)

Authors:
Coomans, M; Dirven, L; Bottomley, A; van den Bent, M; Sloan, J; Stupp, R; Weller, M; Reijneveld, J C; Taphoorn, M; Aaronson, N; Baumert, B G; Brandes, A A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Talacchi, A
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 3
Page Start:
iii14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making. (6th September 2019)

Authors:
Coomans, M; Taphoorn, M J B; Aaronson, N; Baumert, B G; van den Bent, M; Bottomley, A; Brandes, A A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Stupp, R; Talacchi, A; Weller, M; Wick, W; Reijneveld, J C; Dirven, L
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 3
Page Start:
iii14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗